BioSpace News Archive

Gotham is developing a novel drug class targeting RNA-modifying proteins

Eisai Co., Ltd. announced today that a series of abstracts highlighting updates regarding its in-house discovered Lenvima/Kisplyx (lenvatinib mesylate, “lenvatinib”, selective inhibitor of receptor tyrosine kinases with a novel binding mode) and Halaven (eribulin mesylate, “eribulin”, halichondrin class microtubule dynamics inhibitor) will be presented during the European Society for Medical Oncology (ESMO) 2018 Congress taking place in Munich, Germany, from October 19 to 23, 2018.

Secarna Pharmaceuticals announced today that the Company will receive an EU grant under the ERA-Net Co-fund scheme of the Horizon 2020 Research and Innovation Framework Programme for multidisciplinary and translational research and innovation projects (EuroNanoMed III). The duration of the grant is expected to be three years.

Sinntaxis announces today that it has entered into an option agreement with Acturum for an exclusive license to drug candidate AZD2066 for the development of a potentially pioneering treatment helping stroke survivors recover brain function.

Commercialization Plan Now in Place for BRACAnalysis CDx® As a Companion Diagnostic with Pfizer’s Talazoparib

ObsEva SA today announced that IMPLANT 2 Phase 3 clinical data of its novel, oral, oxytocin receptor antagonist, nolasiban, in patients undergoing IVF were presented at the 74th annual meeting ofthe American Society of Reproductive Medicine (ASRM), taking place in Denver, Colorado, October 6-10, 2018.

Antiepileptic drug use is associated with an increased risk of stroke among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland.

Owlstone Medical today announces the appointment of Dr. Richard A Yost to its Scientific Advisory Board.

Presentation of full TG01 phase I/II clinical trial results in resected pancreatic cancer, by Professor Daniel Palme

The Delta Dental Community Care Foundation recently awarded Healthy Smiles for Kids of Orange County a $50,000 grant to support its Smile Center in Garden Grove, California.